Trial Condition(s):
Sunscreen agents
Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay
Bayer Identifier:
18319
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.
Inclusion Criteria
: - Male or female of an age of 18 to 70 years inclusive; - Fitzpatrick Skin Type I, II and/or III for SPF testing; - Good health as determined from the CRO Subject History Form (SHF); - Signed and dated Informed Consent Form; - Signed and dated Health Insurance Portability and Accountability Act (HIPAA) Form; - An unambiguous minimal erythema dose (MED).
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
6
Trial Dates
Phase
N/A
Could I receive a placebo?
No
Products
BAY987519
Accepts Healthy Volunteers
Yes
Where to Participate
Loading...
Locations
| Locations | |
|---|---|
Locations Investigative Site Union, United States, 07083 | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Prevention
Allocation:
N/A
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1
Primary Outcome
- Evaluation of 2 hours water resistant SPFISO/COLIPA Sun Protection FactorTest Method.Timeframe: 16-24 h post exposure
Additional Information
Copyright © Bayer
Powered by
